An inflammatory pathway to apnea and autonomic dysregulation

Respiratory Physiology and Neurobiology

Volumn 178, Issue 3, 2011, Pages 449-457

  Herlenius, Eric ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brainstem; Dysautonomia; Hypoxia; Inflammation; Neonatal apnea; Prostaglandin

Indexed keywords

ADENOSINE; ALPHA INTERFERON; C REACTIVE PROTEIN; CAFFEINE; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYLXANTHINE; NEUROKININ 1 RECEPTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

APNEA; ARTIFICIAL VENTILATION; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD BRAIN BARRIER; BLOOD OXYGEN TENSION; CHILDHOOD DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; FETUS HYPOXIA; FEVER; GESTATIONAL AGE; HUMAN; HYPOVENTILATION; HYPOXIA; IMMUNE RESPONSE; INFANT DISEASE; INFECTION SENSITIVITY; INFLAMMATION; INFLAMMATORY PATHWAY; LUNG DYSPLASIA; LUNG FUNCTION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATION CENTER; RESPIRATION CONTROL; RESPIRATORY DRIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTION; REVIEW; SLEEP APNEA SYNDROME; SOLITARY TRACT NUCLEUS; UNSPECIFIED SIDE EFFECT; VAGUS NERVE STIMULATION; VIRAL BRONCHIOLITIS; VIRUS INFECTION;

ANIMALS; APNEA; AUTONOMIC NERVOUS SYSTEM DISEASES; BRAIN STEM; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; SIGNAL TRANSDUCTION;

EID: 80052465634     PISSN: 15699048     EISSN: 18781519     Source Type: Journal    
DOI: 10.1016/j.resp.2011.06.026     Document Type: Review

References (107)

1. Alvaro R.E., Hasan S.U., Chemtob S., Qurashi M., Al-Saif S., Rigatto H. Prostaglandins are responsible for the inhibition of breathing observed with a placental extract in fetal sheep. Respir. Physiol. Neurobiol. 2004, 144:35-44.
2. Asano K., Nakamura H., Lilly C.M., Klagsbrun M., Drazen J.M. Interferon gamma induces prostaglandin G/H synthase-2 through an autocrine loop via the epidermal growth factor receptor in human bronchial epithelial cells. J. Clin. Invest. 1997, 99:1057-1063.
3. Ballanyi K., Lalley P.M., Hoch B., Richter D.W. cAMP-dependent reversal of opioid- and prostaglandin-mediated depression of the isolated respiratory network in newborn rats. J. Physiol. 1997, 504(Pt 1):127-134.
4. Barrington K., Finer N. The natural history of the appearance of apnea of prematurity. Pediatr. Res. 1991, 29:372-375.
5. Berne R.M. Adenosine: an important physiological regulator. Trends Neurosci. 1986, 1:163-167.
6. Bishop N.C., Fitzgerald C., Porter P.J., Scanlon G.A., Smith A.C. Effect of caffeine ingestion on lymphocyte counts and subset activation in vivo following strenuous cycling. Eur. J. Appl. Physiol. 2005, 93:606-613.
7. Blanco C.E., Martin C.B., Hanson M.A., McCooke H.B. Determinants of the onset of continuous air breathing at birth. Eur. J. Obstet. Gynecol. Reprod. Biol. 1987, 26:183-192.
8. Bruhn F.W., Mokrohisky S.T., McIntosh K. Apnea associated with respiratory syncytial virus infection in young infants. J. Pediatr. 1977, 90:382-386.
9. Bush J.R., Wevrick R. Loss of Necdin impairs myosin activation and delays cell polarization. Genesis 2010, 48:540-553.
10. Carter W.A., De Clercq E. Viral infection and host defense. Science 1974, 186:1172-1178.
11. Coceani F., Akarsu E.S. Prostaglandin E2 in the pathogenesis of fever. An update. Ann. N. Y. Acad. Sci. 1998, 856:76-82.
12. Conti B., Tabarean I., Andrei C., Bartfai T. Cytokines and fever. Front. Biosci. 2004, 9:1433-1449.
13. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 1991, 542:330-335.
14. Cutz E., Ma T.K., Perrin D.G., Moore A.M., Becker L.E. Peripheral chemoreceptors in congenital central hypoventilation syndrome. Am. J. Respir. Crit. Care Med. 1997, 155:358-363.
15. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann. N. Y. Acad. Sci. 2001, 933:222-234.
16. Darnall R.A., Ariagno R.L., Kinney H.C. The late preterm infant and the control of breathing, sleep, and brainstem development: a review. Clin. Perinatol. 2006, 33:883-914. (abstract x).
17. Davis P.G., Schmidt B., Roberts R.S., Doyle L.W., Asztalos E., Haslam R., Sinha S., Tin W. Caffeine for apnea of prematurity trial: benefits may vary in subgroups. J. Pediatr. 2010, 156:382-387.
18. Dawes G.S. The central control of fetal breathing and skeletal muscle movements. J. Physiol. 1984, 346:1-18.
19. De Clercq E. Interferon: ten stories in one. A short review of some of the highlights in the history of an almost quinquagenarian. Acta Microbiol. Immunol. Hung. 2005, 52:273-289.
20. Degi R., Bari F., Thrikawala N., Beasley T.C., Thore C., Louis T.M., Busija D.W. Effects of anoxic stress on prostaglandin H synthase isoforms in piglet brain. Brain Res. Dev. Brain Res. 1998, 107:265-276.
21. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
22. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family. Annu. Rev. Immunol. 2009, 27:519-550.
23. Dinarello C.A. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 2011, 10.1182/blood-2010-07-273417.
24. Ek M., Arias C., Sawchenko P., Ericsson-Dahlstrand A. Distribution of the EP3 prostaglandin E(2) receptor subtype in the rat brain: relationship to sites of interleukin-1-induced cellular responsiveness. J. Comp. Neurol. 2000, 428:5-20.
25. Ek M., Kurosawa M., Lundeberg T., Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1 beta: role of endogenous prostaglandins. J. Neurosci. 1998, 18:9471-9479.
26. Engblom D., Ek M., Saha S., Ericsson-Dahlstrand A., Jakobsson P.J., Blomqvist A. Prostaglandins as inflammatory messengers across the blood-brain barrier. J. Mol. Med. 2002, 80:5-15.
27. Engblom D., Saha S., Engstrom L., Westman M., Audoly L.P., Jakobsson P.J., Blomqvist A. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 2003, 6:1137-1138.
28. Enocsson H., Sjowall C., Skogh T., Eloranta M.L., Ronnblom L., Wettero J. Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares?. Arthritis Rheum. 2009, 60:3755-3760.
29. Ericsson A., Arias C., Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J. Neurosci. 1997, 17:7166-7179.
30. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 1994, 14:897-913.
31. Fanaroff A.A., Korones S.B., Wright L.L., Verter J., Poland R.L., Bauer C.R., Tyson J.E., Philips J.B., Edwards W., Lucey J.F., Catz C.S., Shankaran S., Oh W. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr. Infect. Dis. J. 1998, 17:593-598.
32. Festen D.A., de Weerd A.W., van den Bossche R.A., Joosten K., Hoeve H., Hokken-Koelega A.C. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J. Clin. Endocrinol. Metab. 2006, 91:4911-4915.
33. Fredholm B.B. Adenosine receptors as drug targets. Exp. Cell Res. 2010, 316:1284-1288.
34. Froen J.F., Akre H., Stray-Pedersen B., Saugstad O.D. Adverse effects of nicotine and interleukin-1beta on autoresuscitation after apnea in piglets: implications for sudden infant death syndrome. Pediatrics 2000, 105:E52.
35. Goehler L.E., Erisir A., Gaykema R.P. Neural-immune interface in the rat area postrema. Neuroscience 2006, 140:1415-1434.
36. Goehler L.E., Gaykema R.P., Hansen M.K., Anderson K., Maier S.F., Watkins L.R. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85:49-59.
37. Goehler L.E., Relton J.K., Dripps D., Kiechle R., Tartaglia N., Maier S.F., Watkins L.R. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 1997, 43:357-364.
38. Gordon F.J. Effect of nucleus tractus solitarius lesions on fever produced by interleukin-1beta. Auton. Neurosci. 2000, 85:102-110.
39. Guerra F.A., Savich R.D., Clyman R.I., Kitterman J.A. Meclofenamate increases ventilation in lambs. J. Dev. Physiol. 1989, 11:1-6.
40. Guerra F.A., Savich R.D., Wallen L.D., Lee C.H., Clyman R.I., Mauray F.E., Kitterman J.A. Prostaglandin E2 causes hypoventilation and apnea in newborn lambs. J. Appl. Physiol. 1988, 64:2160-2166.
41. Guntheroth W.G. Interleukin-1 as intermediary causing prolonged sleep apnea and SIDS during respiratory infections. Med. Hypotheses 1989, 28:121-123.
42. Hammerman C., Zangen D. Indomethacin and apnea of prematurity. Crit. Care Med. 1993, 21:154-155.
43. Hayes M.J., Akilesh M.R., Fukumizu M., Gilles A.A., Sallinen B.A., Troese M., Paul J.A. Apneic preterms and methylxanthines: arousal deficits, sleep fragmentation and suppressed spontaneous movements. J. Perinatol. 2007, 27:782-789.
44. Henckel E., Luthander J., Berggren E., Kapadia H., Naver L., Norman M., Bennet R., Eriksson M. Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002. Pediatr. Infect. Dis. J. 2004, 23:27-31.
45. Henderson-Smart D.J., De Paoli A.G. Prophylactic methylxanthine for prevention of apnoea in preterm infants. Cochrane Database Syst. Rev. 2010, 12:CD000432.
46. Henderson-Smart D.J., Duck-Chong C.G. Fetal lung maturation assessment after administration of glucocorticoid. Med. J. Aust. 1981, 2:535-536.
47. Herlenius E., Aden U., Tang L.Q., Lagercrantz H. Perinatal respiratory control and its modulation by adenosine and caffeine in the rat. Pediatr. Res. 2002, 51:4-12.
48. Herlenius, E., Hofstetter Olsson, A., Jakobsson, P. 2009. Methods Relating to Breathing Disorders. International Patent Application No. WO 2009/063226.
49. Herlenius E., Lagercrantz H. Adenosinergic modulation of respiratory neurones in the neonatal rat brainstem in vitro. J. Physiol. 1999, 518(Pt 1):159-172.
50. Herlenius E., Lagercrantz H., Yamamoto Y. Adenosine modulates inspiratory neurons and the respiratory pattern in the brainstem of neonatal rats. Pediatr. Res. 1997, 42:46-53.
51. Hoch B., Bernhard M. Central apnoea and endogenous prostaglandins in neonates. Acta Paediatr. 2000, 89:1364-1368.
52. Hofstetter A.O. Apnea and Infection in Neonates: Mediatory Role of Interleukin-1Beta and Prostaglandin E2 2006, Department of Women's and Children's Health, Karolinska Institutet, Stockholm.
53. Hofstetter A.O., Herlenius E. Interleukin-1beta depresses hypoxic gasping and autoresuscitation in neonatal DBA/1lacJ mice. Respir. Physiol. Neurobiol. 2005, 146:135-146.
54. Hofstetter A.O., Legnevall L., Herlenius E., Katz-Salamon M. Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term-equivalent age. Acta Paediatr. 2008, 97:285-292.
55. Hofstetter A.O., Saha S., Siljehav V., Jakobsson P.J., Herlenius E. The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9894-9899.
56. Holgert H., Hokfelt T., Hertzberg T., Lagercrantz H. Functional and developmental studies of the peripheral arterial chemoreceptors in rat: effects of nicotine and possible relation to sudden infant death syndrome. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7575-7579.
57. Horrigan L.A., Kelly J.P., Connor T.J. Immunomodulatory effects of caffeine: friend or foe?. Pharmacol. Ther. 2006, 111:877-892.
58. Huston J.M., Tracey K.J. The pulse of inflammation: heart rate variability, the cholinergic anti-inflammatory pathway and implications for therapy. J. Intern. Med. 2011, 269:45-53.
59. Johansson B., Halldner L., Dunwiddie T.V., Masino S.A., Poelchen W., Gimenez-Llort L., Escorihuela R.M., Fernandez-Teruel A., Wiesenfeld-Hallin Z., Xu X.J., Hardemark A., Betsholtz C., Herlenius E., Fredholm B.B. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:9407-9412.
60. Katz-Salamon M. Delayed chemoreceptor responses in infants with apnoea. Arch. Dis. Child. 2004, 89:261-266.
61. Katz-Salamon M.J.B.L.H. Blunted peripheral chemoreceptor response to hyperoxia in a group of infants with bronchopulmonary dysplasia. Pediatr. Pulmonol. 1995, 20:101-106.
62. Kitterman J.A., Liggins G.C., Fewell J.E., Tooley W.H. Inhibition of breathing movements in fetal sheep by prostaglandins. J. Appl. Physiol. 1983, 54:687-692.
63. Koch H., Huh S.E., Elsen F.P., Carroll M.S., Hodge R.D., Bedogni F., Turner M.S., Hevner R.F., Ramirez J.M. Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures. J. Neurosci. 2010, 30:11678-11687.
64. Lagercrantz H. Stress, arousal and gene activation at birth. News Physiol. Sci. 1996, 11:214-218.
65. Lagercrantz H., Slotkin T.A. The stress of being born. Sci. Am. 1986, 254:100-107.
66. Lindgren C., Grogaard J. Reflex apnoea response and inflammatory mediators in infants with respiratory tract infection. Acta Paediatr. 1996, 85:798-803.
67. Liu C., Shen F.M., Le Y.Y., Kong Y., Liu X., Cai G.J., Chen A.F., Su D.F. Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Crit. Care Med. 2009, 37:634-641.
68. Marnell L., Mold C., Du Clos T.W. C-reactive protein: ligands, receptors and role in inflammation. Clin. Immunol. 2005, 117:104-111.
69. Martin R.J., Fanaroff A.A. Neonatal apnea, bradycardia, or desaturation: does it matter?. J. Pediatr. 1998, 132:758-759.
70. Martin R.J., Wilson C.G. What to do about apnea of prematurity?. J. Appl. Physiol. 2009, 107:1015-1016.
71. Marty V., El Hachmane M., Amedee T. Dual modulation of synaptic transmission in the nucleus tractus solitarius by prostaglandin E2 synthesized downstream of IL-1beta. Eur. J. Neurosci. 2008, 27:3132-3150.
72. Mathew O.P. Apnea of prematurity: pathogenesis and management strategies. J. Perinatol. 2011, 31:302-310. 10.1038/jp.2010.126.
73. McKay L.C., Feldman J.L. Unilateral ablation of pre-Bötzinger complex disrupts breathing during sleep but not wakefulness. Am. J. Respir. Crit. Care Med. 2008, 178:89-95.
74. Moon R.Y., Horne R.S., Hauck F.R. Sudden infant death syndrome. Lancet 2007, 370:1578-1587.
75. Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., O'Brien K.L., Roca A., Wright P.F., Bruce N., Chandran A., Theodoratou E., Sutanto A., Sedyaningsih E.R., Ngama M., Munywoki P.K., Kartasasmita C., Simoes E.A., Rudan I., Weber M.W., Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010, 375:1545-1555.
76. Nakamura K., Kaneko T., Yamashita Y., Hasegawa H., Katoh H., Negishi M. Immunohistochemical localization of prostaglandin EP3 receptor in the rat nervous system. J. Comp. Neurol. 2000, 421:543-569.
77. Ohta A., Lukashev D., Jackson E.K., Fredholm B.B., Sitkovsky M. 1,3,7-Trimethylxanthine (caffeine) may exacerbate acute inflammatory liver injury by weakening the physiological immunosuppressive mechanism. J. Immunol. 2007, 179:7431-7438.
78. Olsson A., Kayhan G., Lagercrantz H., Herlenius E. IL-1 beta depresses respiration and anoxic survival via a prostaglandin-dependent pathway in neonatal rats. Pediatr. Res. 2003, 54:326-331.
79. Paterson D.S., Hilaire G., Weese-Mayer D.E. Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome. Respir. Physiol. Neurobiol. 2009, 168:133-143.
80. Paton J.F., Abdala A.P., Koizumi H., Smith J.C., St-John W.M. Respiratory rhythm generation during gasping depends on persistent sodium current. Nat. Neurosci. 2006, 9:311-313.
81. Peng W.H., Zhuang J.G., Harrod K.S., Xu F.D. Respiratory syncytial virus infection in anesthetized weanling rather than adult rats prolongs the apneic responses to right atrial injection of capsaicin. J. Appl. Physiol. 2007, 102:2201-2206.
82. Picard N., Guenin S., Larnicol N., Perrin Y. Maternal caffeine ingestion during gestation and lactation influences respiratory adaptation to acute alveolar hypoxia in newborn rats and adenosine A2A and GABA A receptor mRNA transcription. Neuroscience 2008, 156:630-639.
83. Prandota J. Possible pathomechanisms of sudden infant death syndrome: key role of chronic hypoxia, infection/inflammation states, cytokine irregularities, and metabolic trauma in genetically predisposed infants. Am. J. Ther. 2004, 11:517-546.
84. Rohdin M., Fernell E., Eriksson M., Albage M., Lagercrantz H., Katz-Salamon M. Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr. Neurol. 2007, 37:338-344.
85. Roux J.C., Brismar H., Aperia A., Lagercrantz H. Developmental changes in HIF transcription factor in carotid body: relevance for O2 sensing by chemoreceptors. Pediatr. Res. 2005, 58:53-57.
86. Schiller O., Levy I., Pollak U., Kadmon G., Nahum E., Schonfeld T. Central apnoeas in infants with bronchiolitis admitted to the paediatric intensive care unit. Acta Paediatr. 2011, 100:216-219.
87. Schmidt B. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?. J. Pediatr. 1999, 135:526-528.
88. Schmidt B., Davis P., Moddemann D., Ohlsson A., Roberts R.S., Saigal S., Solimano A., Vincer M., Wright L.L. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N. Engl. J. Med. 2001, 344:1966-1972.
89. Schmidt B., Roberts R.S., Davis P., Doyle L.W., Barrington K.J., Ohlsson A., Solimano A., Tin W. Long-term effects of caffeine therapy for apnea of prematurity. N. Engl. J. Med. 2007, 357:1893-1902.
90. Schmidt B., Roberts R.S., Fanaroff A., Davis P., Kirpalani H.M., Nwaesei C., Vincer M. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP). J. Pediatr. 2006, 148:730-734.
91. Stock C., Teyssier G., Pichot V., Goffaux P., Barthelemy J.C., Patural H. Autonomic dysfunction with early respiratory syncytial virus-related infection. Auton. Neurosci. 2010, 156:90-95.
92. Stoltenberg L., Sundar T., Almaas R., Storm H., Rognum T.O., Saugstad O.D. Changes in apnea and autoresuscitation in piglets after intravenous and intrathecal interleukin-1 beta injection. J. Perinat. Med. 1994, 22:421-432.
93. Tai T.C., Adamson S.L. Developmental changes in respiratory, febrile, and cardiovascular responses to PGE2 in newborn lambs. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 278:R1460-R1473.
94. Takita K., Herlenius E., Lindahl S.G., Yamamoto Y. Age- and temperature-dependent effects of opioids on medulla oblongata respiratory activity: an in vitro study in newborn rat. Brain Res. 1998, 800:308-311.
95. Tauber M., Diene G., Molinas C., Hebert M. Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am. J. Med. Genet. A 2008, 146:881-887.
96. Tauman R., Ivanenko A., O'Brien L.M., Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004, 113:e564-e569.
97. Thorburn G.D. The placenta, PGE2 and parturition. Early Hum. Dev. 1992, 29:63-73.
98. Thorburn G.D. The placenta and the control of fetal breathing movements. Reprod. Fertil. Dev. 1995, 7:577-594.
99. Thurston J.H., Hauhard R.E., Dirgo J.A. Aminophylline increases cerebral metabolic rate and decreases anoxic survival in young mice. Science 1978, 201:649-651.
100. Valdez R.C., Ahlawat R., Wills-Karp M., Nathan A., Ezell T., Gauda E.B. Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants. J. Pediatr. 2011, 158:57-64.
101. Vancheri C., Mastruzzo C., Sortino M.A., Crimi N. The lung as a privileged site for the beneficial actions of PGE2. Trends Immunol. 2004, 25:40-46.
102. Walker D.W., Lee B., Nitsos I. Effect of hypoxia on respiratory activity in the foetus. Clin. Exp. Pharmacol. Physiol. 2000, 27:110-113.
103. Weber M.A., Klein N.J., Hartley J.C., Lock P.E., Malone M., Sebire N.J. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 2008, 371:1848-1853.
104. Weese-Mayer D.E., Berry-Kravis E.M., Ceccherini I., Rand C.M. Congenital central hypoventilation syndrome (CCHS) and sudden infant death syndrome (SIDS): kindred disorders of autonomic regulation. Respir. Physiol. Neurobiol. 2008, 164:38-48.
105. Wendler C.C., Busovsky-McNeal M., Ghatpande S., Kalinowski A., Russell K.S., Rivkees S.A. Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J. 2009, 23:1272-1278.
106. Yang J., Xia M., Goetzl E.J., An S. Cloning and expression of the EP3-subtype of human receptors for prostaglandin E2. Biochem. Biophys. Res. Commun. 1994, 198:999-1006.
107. Yang J.N., Bjorklund O., Lindstrom-Tornqvist K., Lindgren E., Eriksson T.M., Kahlstrom J., Chen J.F., Schwarzschild M.A., Tobler I., Fredholm B.B. Mice heterozygous for both A1 and A(2A) adenosine receptor genes show similarities to mice given long-term caffeine. J. Appl. Physiol. 2009, 106:631-639.